Looking over the sources for my last post, an anvil hit me: according to World Health Organization (WHO) estimates here, on a global basis, 45% of health budgets is spent on diabetes and diabetes-related illnesses. That would make diabetes, by most counts, the world's leading disease, overshadowing even AIDS in sheer scope and costs!! Think about it.

OH BUT WAIT: That site features a dreaded Statistical Typo, in which all short dashes have mysteriously disappeared... double-checking the original British source site, that would be 4-5% of health budgets spent on diabetes, an "expenditure also forecast to increase rapidly."

Hockey_stickRight... whew! Had me going there for a minute. But there are a number of quite eye-opening (and accurate) additional factoids to wrap your head around:

- A person with diabetes incurs medical costs that are two to five times higher* than those of a person without

- WHO estimated 30m people worldwide had some form of diabetes in 1985

- by 2000, the number had increased to 177m

- WHO projections now suggest that the number of people suffering from diabetes will reach nearly 370m by 2030

- the American market for

diabetes drugs and supplies has grown rapidly in recent years, to account for

57% of world sales, compared with less than 50% in 1998

- The diabetes market is concentrated in the hands of six key players, who

account for 75% of global diabetes sales:

1) Eli Lilly, with ca. 16% market share

2) Takeda (Japan - Actos), with almost 15% share

3) Novo Nordisk

4) GlaxoSmithKline (GSK)

5) Bristol Myers Squibb (BMS)

7) Aventis

- oral antidiabetics, insulins, and other "innovative products" for diabetes face increasing competition from lower-priced generics and, in Europe, parallel imports (*Considering the first item, above, Thank God for that, at least!)

Disclaimer: Content created by the Diabetes Mine team. For more details click here.


This content is created for Diabetes Mine, a consumer health blog focused on the diabetes community. The content is not medically reviewed and doesn't adhere to Healthline's editorial guidelines. For more information about Healthline's partnership with Diabetes Mine, please click here.